Twist Bioscience公布2026财年三季度业绩，收入超预期但每股亏损不及预期

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
Aug 03, 2026
PDF Version
SOUTH SAN FRANCISCO, Calif.
--(BUSINESS WIRE)--Aug. 3, 2026--
Twist Bioscience Corporation
(NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the third quarter fiscal 2026 ended
June 30, 2026
.
Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at
www.twistbioscience.com
to view the
detailed fiscal third quarter 2026 earnings report
and the
investor presentation,
or click
https://investors.twistbioscience.com/events-and-presentations
.
The company plans to hold a conference call and live audio webcast for analysts and investors at
8:00 a.m. Eastern Time
today to discuss its financial results and provide an update on the company’s business. The conference call will be webcast live through the Investor Relations section under the “Company” tab at
www.twistbioscience.com
. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking
here
. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.
About Twist Bioscience Corporation
At Twist Bioscience, our customizable solutions across the biological continuum raise the bar in diagnostics, therapeutics, industrial, agriculture and research markets.
We drive innovation with confidence, without compromise. Whether delivering oligos, genes, proteins, libraries, characterization data, antibody discovery solutions, or NGS workflow tools, our scientific expertise and exceptional customer experience help navigate complex challenges, all with precision and at the scale and speed customers require. By enhancing R&D efficiency at every turn, we give scientists more shots on goal – more experiments, more iterations, more chances for remarkable discoveries.
Together, we stand with customers in the relentless pursuit of progress, backed by enterprise reliability, to shape a healthier and more sustainable future for all. For more information about our products and services, please visit
www.twistbioscience.com
.
Follow us on
LinkedIn
|
X
|
YouTube
|
Instagram
|
Bluesky
View source version on businesswire.com:
https://www.businesswire.com/news/home/20260803142480/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
Print Page
Email Page
Email Alerts
RSS Feeds